RCKSX
Price
$21.41
Change
+$0.25 (+1.18%)
Updated
Sep 26 closing price
Net Assets
12.57M
VIMSX
Price
$79.84
Change
+$0.88 (+1.11%)
Updated
Sep 26 closing price
Net Assets
199.16B
Interact to see
Advertisement

RCKSX vs VIMSX

Header iconRCKSX vs VIMSX Comparison
Open Charts RCKSX vs VIMSXBanner chart's image
Rock Oak Core Growth
Price$21.41
Change+$0.25 (+1.18%)
VolumeN/A
Net Assets12.57M
Vanguard Mid Cap Index Investor
Price$79.84
Change+$0.88 (+1.11%)
VolumeN/A
Net Assets199.16B
RCKSX vs VIMSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RCKSX vs. VIMSX commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RCKSX is a Hold and VIMSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 199B vs. RCKSX (12.6M). VIMSX pays higher dividends than RCKSX: VIMSX (1.35) vs RCKSX (0.22). RCKSX was incepted earlier than VIMSX: RCKSX (21 years) vs VIMSX (27 years). RCKSX (1.53) is less costly to investors than VIMSX (0.17). VIMSX is a more actively managed with annual turnover of: 16.00 vs. RCKSX (11.00). RCKSX has a lower initial minimum investment than VIMSX: RCKSX (2000) vs VIMSX (3000). VIMSX annual gain was more profitable for investors over the last year : 11.57 vs. RCKSX (9.44). VIMSX return over 5 years is better than : 70.75 vs. RCKSX (28.27).
RCKSXVIMSXRCKSX / VIMSX
Total Expense Ratio1.250.17735%
Annual Report Gross Expense Ratio1.530.17900%
Fund Existence21 years27 years-
Gain YTD11.22110.845103%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets12.6M199B0%
Annual Yield % from dividends0.221.3516%
Returns for 1 year9.4411.5782%
Returns for 3 years52.4055.7494%
Returns for 5 years28.2770.7540%
Returns for 10 years88.80160.6655%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LXRX1.400.06
+4.48%
Lexicon Pharmaceuticals
APGE38.220.70
+1.87%
Apogee Therapeutics
ASTS49.09-0.30
-0.61%
AST SpaceMobile
JDZG1.81-0.02
-1.09%
Jiade Limited
LIDR2.36-0.03
-1.26%
AEye